What is Harvard Bioscience Inc's Market Cap?

Harvard Bioscience Inc's Market Cap is $36.2M, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's Enterprise Value?

Harvard Bioscience Inc's Enterprise Value is $66.4M, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's Price / Sales?

Harvard Bioscience Inc's Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's EV / Revenue?

Harvard Bioscience Inc's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's EV / EBITDA?

Harvard Bioscience Inc's EV / EBITDA is 13.6×, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's Revenue (TTM)?

Harvard Bioscience Inc's Revenue (TTM) is $87.8M, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's Net Income (TTM)?

Harvard Bioscience Inc's Net Income (TTM) is -$10.4M, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's EBITDA?

Harvard Bioscience Inc's EBITDA is $4.9M, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's Diluted EPS (TTM)?

Harvard Bioscience Inc's Diluted EPS (TTM) is -2.29, based on as-reported figures from SEC (XBRL) filings.

What is Harvard Bioscience Inc's EBITDA Margin?

Harvard Bioscience Inc's EBITDA Margin is 5.6%, based on as-reported figures from SEC (XBRL) filings.

Harvard Bioscience Inc (HBIO) Financial Statements

Harvard Bioscience Inc

SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS

FIGI BBG001SG1ML8

XNAS · usd

7.95▼ 0.07 (-0.87%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close8.02

Day's Range7.85 – 8.15

52-Week Range0.38 – 8.40

Volume12.3K

Avg Volume20.4K

Share Statistics

Shares Outstanding

Employees339

ExchangeXNAS

Listed2000-12-07

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Harvard Bioscience Inc (HBIO)

What is Harvard Bioscience Inc's Market Cap?: Harvard Bioscience Inc's Market Cap is $36.2M, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's Enterprise Value?: Harvard Bioscience Inc's Enterprise Value is $66.4M, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's Price / Sales?: Harvard Bioscience Inc's Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's EV / Revenue?: Harvard Bioscience Inc's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's EV / EBITDA?: Harvard Bioscience Inc's EV / EBITDA is 13.6×, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's Revenue (TTM)?: Harvard Bioscience Inc's Revenue (TTM) is $87.8M, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's Net Income (TTM)?: Harvard Bioscience Inc's Net Income (TTM) is -$10.4M, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's EBITDA?: Harvard Bioscience Inc's EBITDA is $4.9M, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's Diluted EPS (TTM)?: Harvard Bioscience Inc's Diluted EPS (TTM) is -2.29, based on as-reported figures from SEC (XBRL) filings.
What is Harvard Bioscience Inc's EBITDA Margin?: Harvard Bioscience Inc's EBITDA Margin is 5.6%, based on as-reported figures from SEC (XBRL) filings.